Invesco Ltd. Champions Oncology, Inc. Transaction History

Invesco Ltd.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$8.39 - $13.27 $203,591 - $322,009	-24,266 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$7.05 - $10.2 $113,779 - $164,617	-16,139 Reduced 39.94%	24,266 $224,000
Q2 2020 Aug 14, 2020	BUY	$6.65 - $9.84 $15,594 - $23,074	2,345 Added 6.16%	40,405 $387,000
Q1 2020 May 15, 2020	BUY	$4.19 - $8.62 $33,939 - $69,822	8,100 Added 27.04%	38,060 $281,000
Q4 2019 Feb 14, 2020	SELL	$5.12 - $8.33 $42,649 - $69,388	-8,330 Reduced 21.76%	29,960 $250,000
Q3 2019 Nov 14, 2019	SELL	$5.4 - $8.99 $10,260 - $17,081	-1,900 Reduced 4.73%	38,290 $217,000
Q2 2019 Aug 14, 2019	SELL	$7.51 - $10.12 $76,977 - $103,729	-10,250 Reduced 20.32%	40,190 $315,000
Q1 2019 May 15, 2019	SELL	$7.89 - $12.23 $11,527 - $17,868	-1,461 Reduced 2.81%	50,440 $493,000
Q4 2018 Feb 14, 2019	BUY	$7.29 - $15.27 $378,358 - $792,528	51,901 New	51,901 $405,000

5.81M

3.3K

6.1K

Ticker CSBR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,522,400
Market Cap $53.7M
Description
Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Techn...

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

Stay updated on Invesco Ltd. with notifications on news.